V Fontana Selected Research

Matrix Metalloproteinases (MMPs)

5/2010

Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

V Fontana Research Topics

Disease

3	Hypertension (High Blood Pressure) 05/2015 - 05/2010
2	Hypersensitivity (Allergy) 01/2019 - 01/2016
2	Thrombosis (Thrombus) 06/2008 - 01/2008
2	Neoplasms (Cancer) 11/2000 - 03/2000
1	Acute Coronary Syndrome 11/2020
1	Barrett Esophagus (Barrett's Esophagus) 01/2017
1	Esophagitis 01/2017
1	Needlestick Injuries (Needlestick Injury) 01/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Allergic Rhinitis 01/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Alkalosis 01/2016
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 06/2014
1	Renovascular Hypertension (Goldblatt Syndrome) 05/2010
1	Atherosclerosis 01/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2008
1	Carcinoma (Carcinomatosis) 10/2001
1	Malignant Mesothelioma 11/2000
1	Herpes Zoster 07/2000
1	Lung Neoplasms (Lung Cancer) 03/2000
1	Mesothelioma 03/2000

Drug/Important Bio-Agent (IBA)

2	Immunoglobulin E (IgE)IBA 01/2019 - 01/2016
1	Pharmaceutical PreparationsIBA 11/2020
1	TeaIBA 01/2017
1	Coffee FDA Link 01/2017
1	AllergensIBA 01/2016
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2016
1	Antihypertensive Agents (Antihypertensives)IBA 05/2015
1	AdipokinesIBA 06/2014
1	AntioxidantsIBA 05/2010
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 05/2010
1	Spironolactone (Aldactone)FDA LinkGeneric 05/2010
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2010
1	Matrix Metalloproteinases (MMPs)IBA 05/2010
1	Thrombin FDA Link 06/2008
1	EnzymesIBA 10/2001
1	ImmunosorbentsIBA 10/2001
1	Oncogene Proteins (Oncogene Protein)IBA 10/2001
1	Therapeutic UsesIBA 11/2000
1	Coal (Coals)IBA 07/2000
1	Environmental Pollutants (Pollutants, Environmental)IBA 07/2000
1	Petroleum (Crude Oil)IBA 03/2000
1	AsbestosIBA 03/2000

Therapy/Procedure

1	Polypharmacy 11/2020
1	Protective Devices (Safety Device) 01/2016
1	Noninvasive Ventilation 01/2016
1	Catheters 01/2016
1	Therapeutics 05/2015
1	Surgical Instruments (Clip) 05/2010
1	Splenectomy 01/2008
1	Drug Therapy (Chemotherapy) 10/2001